Ga. Comp. R. & Regs. R. 480-34-.12 - Synthetic Fentanyl

(a) This rule was adopted to protect the health, safety, and welfare of the public. This rule places newly identified compounds, including any derivatives, their salts, isomers, or salts of isomers, unless specifically utilized as part of the manufacturing process by a commercial industry of a substance or material not intended for human ingestion or consumption, as a prescription administered under medical supervision, or for research at a recognized institution, whenever the existence of these salts, isomers, or salts of isomers is possible within the specific chemical designation or unless specifically excepted or listed in this or another schedule, structurally derived from fentanyl, and whether or not further modified in any of the following ways under Schedule I of the Georgia Controlled Substances Act, Section 16-13-25(13)as follows:

(H) Tetrahydrofuran fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide)

(b) This rule is based on the following findings of the Board:

(1) That synthetic fentanyls have an extremely high potential for abuse;

(2) That scientific evidence and scientific knowledge of the pharmacological effects of these compounds demonstrate that the public is at extreme risk if they are not regulated as controlled substances;

(3) That the pattern of abuse of these compounds and the scope and significance of that abuse support regulation;

(4) That there exists an imminent peril to the public health and welfare with regard to the abuse of these compounds;

(5) That these compounds have the same risk to the public health of citizens of the State of Georgia as other substances already contained in Schedule I under the Controlled Substances Act; and

(6) That these compounds have no known precursor already scheduled under the Act.

Notes

Ga. Comp. R. & Regs. R. 480-34-.12

O.C.G.A. §§ 16-13-22, 16-13-25, 26-4-28, 50-13-4.

Original Rule entitled "Synthetic Fentanyl" adopted. F. Feb. 22, 2018; eff. Mar. 14, 2018.